share_log

福安药业(300194.SZ):盐酸咪哒唑仑获得化学原料药上市申请批准通知书

Fuan Pharmaceutical (300194.SZ): Midazolam hydrochloride obtained approval notice for the marketing application of chemical raw materials

Zhitong Finance ·  Apr 9 07:58

Fuan Pharmaceutical (300194.SZ) announced that Fuan Pharmaceutical Group Chongqing Bosheng Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company...

Zhitong Finance App News, Fu'an Pharmaceutical (300194.SZ) announced that Fuan Pharmaceutical Group Chongqing Bosheng Pharmaceutical Co., Ltd. (“Bosheng Pharmaceutical”), a wholly-owned subsidiary of the company, recently received a notice of approval for the marketing application of chemical raw materials issued by the State Drug Administration. The name of the active ingredient is midazolam hydrochloride, mainly used for pre-anesthetic administration, induction and maintenance of general anesthesia, adjuvant medication, diagnostic or therapeutic procedures during local anesthesia (such as radiography, cardiac arrhythmia, bronchoscopy, gastrointestinal endoscopic examination) Patient sedation during microscopy, etc.), ICU patient sedation .

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment